J&J Hit With $1.8M Verdict In Levaquin MDL
A federal jury on Wednesday awarded $1.8 million to a Minnesota man who claimed that taking Johnson & Johnson's antibiotic Levaquin to treat a respiratory infection contributed to tears in his...To view the full article, register now.
Already a subscriber? Click here to view full article